Skip to content

FundPlus

FundPlus is a Belgian private foundation focused on long-term equity investments in innovative life sciences companies, primarily in therapeutics, diagnostics, and medical devices. It aims to create sustainable shareholder value and contribute to the life sciences sector.

Founded
2015
Recorded stages
Series A, Series B
Focus sectors
Biotech, Healthcare
Recorded regions
Europe

Online destinations

Find FundPlus online

Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.

Official links

Pages the organization runs itself.

Overview

FundPlus is a private foundation established in May 2015 by Désiré Collen and the non-profit organization Life Sciences Research Partners. Based in Leuven, Belgium, it operates as a Belgian Naamloze Vennootschap/Société Anonyme (NV/SA). FundPlus focuses on long-term equity investments in innovative life sciences companies, primarily in therapeutics, diagnostics, and medical devices. The fund aims to create sustainable shareholder value and contribute to the development of the life sciences sector while generating a beneficial societal impact. As of now, FundPlus has raised €200 million in financing commitments.

Focus

Fund+ invests in innovative life sciences companies that are primarily active in therapeutics, diagnostics, and medical devices. The fund targets companies seeking Series A or B financing that have already achieved proof of concept. The intended investment size per company ranges from €5 million to €15 million, distributed over various milestones. Fund+ aims to be a significant minority shareholder (more than 10%) and plays a constructive role as a board member in its portfolio companies, focusing on investments in Europe, particularly Belgium.

Support

Fund+ adds value to its portfolio companies by taking significant minority stakes and actively participating as board members, providing strategic guidance and support to help them achieve their milestones and grow sustainably.

Questions

What are FundPlus's investment criteria?

FundPlus invests in innovative life sciences companies primarily in therapeutics, diagnostics, and medical devices. They target Series A and B financing for companies that have achieved proof of concept.

How can I apply or pitch to FundPlus?

Founders can pitch to FundPlus by sending an email to info@fundplus.be. It is advisable to include a detailed business plan and financial projections in the pitch.

What makes FundPlus different from other venture capital firms?

FundPlus distinguishes itself through its commitment to societal impact alongside shareholder value. The firm actively participates as a board member in its portfolio companies, providing strategic guidance and support.

What is the geographic scope of FundPlus's investments?

FundPlus primarily focuses on investments in Europe, with a strong emphasis on Belgium. This regional focus allows them to leverage local expertise and networks.

What is the typical fund size and check size for FundPlus?

FundPlus has raised €200 million in financing commitments, with typical check sizes ranging from €5 million to €15 million per investment.

What is FundPlus's post-investment involvement like?

FundPlus takes significant minority stakes in its portfolio companies and plays an active role as a board member, helping guide strategic decisions and support growth initiatives.

Check your startup’s fit

Check your startup’s fit with FundPlus

Similar investors

Organizations that do similar work to FundPlus.

All investors
Keiretsu Forum logoInvestor

Global investment community for angel investors and venture capitalists.

Value8 N.V. logoInvestor

Investing in the future of small and medium enterprises.

Hamilton Lane logoInvestor

Investing in private markets for over 30 years.

Magnetar logoInvestor

Innovative investment solutions across diverse asset classes.

Superscout Pro

Find faster. Show up verified. Keep your deals private.

$99a year, or $12 a month
Get Pro

Is this page right?Reviewed · How the research works

Something's off